Company intelligence / Profile preview

Fermentalg

Libourne, Nouvelle-Aquitaine, Francefermentalg.com ↗

Ownership: Private
Employees: ~58
Development stage: Commercial

Overview

Fermentalg has successfully commercialized several microalgae-derived products including DHA-enriched omega‑3 oils for human health, natural blue pigments for food coloring, and high-protein biomass as an alternative to spirulina. The company also collaborates on environmental projects such as carbon capture using microalgae. No clinical trial results are reported since the focus is on nutrition and industrial biotech rather than pharmaceuticals.

Therapeutic areas: Metabolic DisordersOther
Modalities: Microbial therapy (microalgae-based products)Protein (alternative proteins)Lipid (omega‑3 oils)Natural pigment (phycocyanin)
Industry: Non-Drug Biotech

Partnerships

SUEZ – collaboration for environmental solutions such as carbon sinks/carbon capture

Beyond the preview

Go deeper on Fermentalg.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fermentalg.

Explore the full profile